Subanalysis of COPD exacerbations by severity of airflow obstruction according to NICE criteria at baseline also showed a numerical trend towards lower incidence in the tiotropium group compared with placebo across severity categories (Table 5 ).
← all excerpts
Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study.
1
—
—